SAA positivity rate amongst dual LRRK2-GBA1, GBA1 and LRRK2 carriers with Parkinson’s disease
Authors:
- Penina PongerPPPenina Ponger
- Anuprita R NairANAnuprita R Nair
- The Parkinson’S Progression Markers InitiativeTIThe Parkinson’S Progression Markers Initiative
Preprint
Abstract
We investigated whether people with Parkinson’s disease who are dual GBA1+LRRK2 carriers have a milder, LRRK2-like phenotype as previously reported. This was accomplished by comparing clinical features and alpha-synuclein seed amplification assay (SAA) positivity rates between dual GBA1+LRRK2-PD(n=13), GBA1-PD(n=169) and LRRK2-PD(n=175) carriers in a cross-sectional retrospective study of Parkinson’s Progression Markers Initiative (PPMI) data. Our results show that GBA1+LRRK2-PD SAA positivity rate(83%) is closer to GBA1-PD rate(87%) rather than LRRK2-PD rate(62%,p-value>0.05). GBA1+LRRK2-PD have both non-motor and motor phenotypic similarity to GBA1-PD,(p-value>0.05). This small PPMI cohort indicates that dual GBA1+LRRK2-PD carriers’ SAA positivity and phenotype are aligned with GBA1-PD.Keywords
Funding Information
- PPMI
This publication has 21 references indexed in Scilit:
- Precision Medicine in Parkinson’s DiseaseNeurologic Clinics, 2025
- Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein DiseaseAnnals of Neurology, 2024
- Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta‐AnalysisMovement Disorders, 2024
- Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging ApproachCurrent Neurology and Neuroscience Reports, 2023
- Sex and Gender Differences in Parkinson's DiseaseNeurologic Clinics, 2023
- Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson DiseaseJAMA Neurology, 2022
- Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease ProgressionJAMA Network Open, 2021
- A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's DiseaseMovement Disorders, 2020
- Validation of the MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2018
- Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotesJAMA Neurology, 2014